Season 2 - Ep.20: Lifetime management of aortic valve stenosis - Spirituality and cardiovascular health

4 snips

Jul 18, 2024

Guest

Francesco Maisano

Cardiologist Carlos Aguiar, spirituality expert Kavitha Chinnaiyan, and renowned cardiologist Francesco Maisano discuss lifetime management of aortic valve stenosis and the impact of spirituality on cardiovascular health. Topics include personalized therapy options, integrating spirituality in patient care, and the use of AI technology for statistical analyses in medicine.

Ask episode

Chapters

Transcript

Episode notes

Intro

00:00 • 3min

Trials on Blood Pressure Management and Home Treatment for Pulmonary Embolism in Cardiovascular Health

03:11 • 3min

Advancements in Transcatheter Aortic Valve Implantation (TAVI)

06:03 • 7min

Spirituality in Cardiovascular Medicine

12:50 • 6min

Exploring Spirituality in Medicine and Statistical Analysis with ChatGPT

19:13 • 5min

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode covers:

Cardiology this Week: A concise summary of recent studies
Lifetime management of aortic valve stenosis
Spirituality and cardiovascular health
Statistics Made Easy: Statistical Analyses using Chat GPT

Host: Perry Elliott

Guests: Carlos Aguiar, Kavitha Chinnaiyan, Francesco Maisano

Want to watch that episode? Go to: https://esc365.escardio.org/event/1155

Disclaimer

ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb. The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor.

This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

Declarations of interests

Stephan Achenbach, Kavitha Chinnaiyan and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

Giuseppe Biondi-Zoccai has declared to have potential conflicts of interest to report : Aleph, Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Guidotti, Innovheart, Meditrial, Menarini, Microport, Opsens Medical, Terumo, and Translumina.

Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi, Terumo, Medtronic.

Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

Francesco Maisano has declared to have potential conflicts of interest to report : Grant Institute, Edwards, Abbott, NVT, Medtronic, Jenavalve and Boston Scientifics.

Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.